Multivalent pneumococcal polysaccharide-protein conjugate composition

MYPI2026000560A0Undetermined Publication Date: 2019-08-05SANOFI VACCINES US INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2026000560
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-04-18
Filing Date
2019-02-04
Publication Date
2019-08-05
Patent Text Reader

Abstract

Provided are mixed carrier, multivalent pneumococcal conjugate compositions comprising (21) different pneumococcal capsular polysaccharide-protein conjugates, wherein each of the conjugates includes a capsular polysaccharide from a different serotype of Streptococcus pneumonicze conjugated to either tetanus toxoid (TT) or CRM197, wherein the Streptococcus pneumoniae serotypes are selected from (1), (3), (4), (5), (6A), (6B), (7F), (8), (9N), (9V), (bA), (1 1A), (12F), (14), (15B), (‘18C), (19A), (19F), (22F), (23F), and (33F), where the capsular polysaccharides of two of serotypes (1), (3), and (5) and one or both of serotypes (15B) and (22F) are conjugated to TT and the remaining capsular polysaccharides are conjugated to CRM₁₉₇. Also provided are methods of producing the mixed carrier, multivalent pneumococcal conjugate compositions and methods of using the same for prophylaxis against Streptococcus pneumoniae infection or disease in a subject.
Need to check novelty before this filing date? Find Prior Art